Literature DB >> 21389726

Effects of ad libitum ingestion of monosodium glutamate on weight gain in C57BL6/J mice.

Xueying Ren1, Jozélia G Ferreira, Catherine W Yeckel, Takashi Kondoh, Ivan E de Araujo.   

Abstract

Although the umami compound monosodium glutamate (MSG) is a widely used flavor enhancer, controversy still persists regarding the effects of MSG intake on body weight. It has been claimed, in particular, that chronic MSG intake may result in excessive body weight gain and obesity. In this study we assessed the effects of chronic (16 weeks) ad libitum MSG on body weight and metabolism of C57BL6/J mice. Adult male mice were divided in four experimental groups and fed with either a low-fat (LF) or high-fat (HF) diet and with either two bottles of plain water or one bottle containing 1% MSG and another one containing water according to a factorial design. Mice were monitored weekly for body weight and food/fluid intake for 15 weeks. At the end of the experiments, the circulating levels of leptin, insulin, total protein, total cholesterol, triglyceride, blood urea nitrogen, and non-esterified fatty acids were also analyzed. Our results show that MSG intake did not influence body weight in either LF or HF groups. Interestingly, although animals overall displayed strong preferences for MSG against water, preferences were relatively higher in LF compared to HF group. Consistent with the body weight data, while significant differences in leptin, insulin, total cholesterol, and non-esterified fatty acids were found between HF and LF groups, such an effect was not influenced by MSG intake. Finally, indirect calorimetry measurements revealed similar energy expenditure levels between animals being presented water only and MSG only. In summary, our data does not support the notion that ad libitum MSG intake should trigger the development of obesity or other metabolic abnormalities.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21389726     DOI: 10.1159/000323405

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  7 in total

Review 1.  Melanocortin neurons: Multiple routes to regulation of metabolism.

Authors:  Wen-Jie Shen; Ting Yao; Xingxing Kong; Kevin W Williams; Tiemin Liu
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-05-09       Impact factor: 5.187

2.  Dietary supplementation with arginine and glutamic acid enhances key lipogenic gene expression in growing pigs.

Authors:  C J Hu; Q Y Jiang; T Zhang; Y L Yin; F N Li; J Y Su; G Y Wu; X F Kong
Journal:  J Anim Sci       Date:  2017-12       Impact factor: 3.159

3.  Supplementing monosodium glutamate to partial enteral nutrition slows gastric emptying in preterm pigs(1-3).

Authors:  Caroline Bauchart-Thevret; Barbara Stoll; Nancy M Benight; Oluyinka Olutoye; David Lazar; Douglas G Burrin
Journal:  J Nutr       Date:  2013-02-27       Impact factor: 4.798

4.  Monosodium glutamate inhibits the lymphatic transport of lipids in the rat.

Authors:  Alison B Kohan; Qing Yang; Min Xu; Dana Lee; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-08-11       Impact factor: 4.052

5.  Monosodium L-Glutamate and Dietary Fat Differently Modify the Composition of the Intestinal Microbiota in Growing Pigs.

Authors:  Ze-Meng Feng; Tie-Jun Li; Li Wu; Ding-Fu Xiao; Francois Blachier; Yu-Long Yin
Journal:  Obes Facts       Date:  2015-03-10       Impact factor: 3.942

6.  Daily consumption of monosodium glutamate pronounced hypertension and altered renal excretory function in normotensive and hypertensive rats.

Authors:  Nattaya Thongsepee; Pongsakorn Martviset; Pathanin Chantree; Phornphan Sornchuer; Kant Sangpairoj; Parisa Prathaphan; Jittiporn Ruangtong; Siriphun Hiranyachattada
Journal:  Heliyon       Date:  2022-10-05

Review 7.  Can We Selectively Reduce Appetite for Energy-Dense Foods? An Overview of Pharmacological Strategies for Modification of Food Preference Behavior.

Authors:  Ewa Bojanowska; Joanna Ciosek
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.